Discover
RDHL
RedHill Biopharma Ltd.
0.83
2 x 0.62
2 x 1.07
bid
ask
-
0.02
1.79%
2 @ 04:00 PM
0.84 +0.01 (1.01%)
| Ytd | -19.43% | |
| 1y | -58.92% |
0.81
day range
0.88
0.71
52 week range
3.31
| Open | 0.85 | Prev Close | 0.84 | Low | 0.81 | High | 0.88 | Mkt Cap | 4.31M |
| Vol | 50.73K | Avg Vol | 209.55K | EPS | N/A | P/E | N/A | Forward P/E | 210.67 |
| Beta | 3.67 | Short Ratio | 0.37 | Inst. Own | 5.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-10 | 50-d Avg | 0.95 | 200-d Avg | 1.15 | 1yr Est | 19000.00 |
RDHL News
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's
benzinga.com
RedHill Biopharma Commences ~$6M Offering Of American Depositary Shares, Series A-2 Warrants At $0.7
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
Redhill Biopharma Announces FDA Rare Pediatric Disease Designation For Opaganib For The Treatment Of
The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to opagan
benzinga.com
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Re
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
benzinga.com
RedHill Biopharma Engages WHO Solidarity Platform And Pharma Partners To Advance Opaganib As Oral Ho
Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolavir
benzinga.com
RedHill Biopharma Actively Discussing Potential Collaborations For Advancement Of Its Investigationa
Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolaviru